| Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus JC Voltarelli, CEB Couri, ABPL Stracieri, MC Oliveira, DA Moraes, ... Jama 297 (14), 1568-1576, 2007 | 770 | 2007 |
| C-peptide levels and insulin independence following autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus CEB Couri, MCB Oliveira, ABPL Stracieri, DA Moraes, F Pieroni, ... Jama 301 (15), 1573-1579, 2009 | 570 | 2009 |
| Effect of nonmyeloablative hematopoietic stem cell transplantation vs continued disease-modifying therapy on disease progression in patients with relapsing-remitting multiple … RK Burt, R Balabanov, J Burman, B Sharrack, JA Snowden, MC Oliveira, ... Jama 321 (2), 165-174, 2019 | 305 | 2019 |
| Association of nonmyeloablative hematopoietic stem cell transplantation with neurological disability in patients with relapsing-remitting multiple sclerosis RK Burt, R Balabanov, X Han, B Sharrack, A Morgan, K Quigley, K Yaung, ... Jama 313 (3), 275-284, 2015 | 247 | 2015 |
| Cardiac involvement and treatment-related mortality after non-myeloablative haemopoietic stem-cell transplantation with unselected autologous peripheral blood for patients with … RK Burt, MC Oliveira, SJ Shah, DA Moraes, B Simoes, M Gheorghiade, ... The Lancet 381 (9872), 1116-1124, 2013 | 177 | 2013 |
| Cardiopulmonary assessment of patients with systemic sclerosis for hematopoietic stem cell transplantation: recommendations from the European Society for Blood and Marrow … D Farge, RK Burt, MC Oliveira, E Mousseaux, M Rovira, Z Marjanovic, ... Bone Marrow Transplantation 52 (11), 1495-1503, 2017 | 130 | 2017 |
| Brazilian experience with two conditioning regimens in patients with multiple sclerosis: BEAM/horse ATG and CY/rabbit ATG N Hamerschlak, M Rodrigues, DA Moraes, MC Oliveira, ABPL Stracieri, ... Bone marrow transplantation 45 (2), 239-248, 2010 | 110 | 2010 |
| Autologous hematopoietic SCT normalizes miR-16,-155 and-142-3p expression in multiple sclerosis patients LCM Arruda, JCC Lorenzi, APA Sousa, DL Zanette, PVB Palma, ... Bone marrow transplantation 50 (3), 380-389, 2015 | 103 | 2015 |
| Immune rebound associates with a favorable clinical response to autologous HSCT in systemic sclerosis patients LCM Arruda, KCR Malmegrim, JR Lima-Júnior, E Clave, JBE Dias, ... Blood Advances 2 (2), 126-141, 2018 | 94 | 2018 |
| Immunological balance is associated with clinical outcome after autologous hematopoietic stem cell transplantation in type 1 diabetes KCR Malmegrim, JLTC De Azevedo, LCM Arruda, JRF Abreu, CEB Couri, ... Frontiers in immunology 8, 167, 2017 | 89 | 2017 |
| Autologous stem cell transplantation for progressive systemic sclerosis: a prospective non-interventional study from the European Society for Blood and Marrow Transplantation … J Henes, MC Oliveira, M Labopin, M Badoglio, HU Scherer, N Del Papa, ... haematologica 106 (2), 375, 2021 | 80 | 2021 |
| Immunological correlates of favorable long-term clinical outcome in multiple sclerosis patients after autologous hematopoietic stem cell transplantation LCM Arruda, JTC de Azevedo, GLV de Oliveira, GT Scortegagna, ... Clinical Immunology 169, 47-57, 2016 | 77 | 2016 |
| Autologous hematopoietic stem cell transplantation in neuromyelitis optica: a registry study of the EBMT Autoimmune Diseases Working Party R Greco, A Bondanza, MC Oliveira, M Badoglio, J Burman, F Piehl, ... Multiple Sclerosis Journal 21 (2), 189-197, 2015 | 73 | 2015 |
| Xenogeneic mesenchymal stromal cells improve wound healing and modulate the immune response in an extensive burn model C Caliari-Oliveira, JNU Yaochite, LNZ Ramalho, PVB Palma, D Carlos, ... Cell transplantation 25 (2), 201-215, 2016 | 65 | 2016 |
| Bone marrow mesenchymal stromal cells isolated from multiple sclerosis patients have distinct gene expression profile and decreased suppressive function compared with healthy … GLV De Oliveira, KWA De Lima, AM Colombini, DG Pinheiro, ... Cell transplantation 24 (2), 151-165, 2015 | 64 | 2015 |
| Autologous hematopoietic stem cell transplantation for type 1 diabetes JC Voltarelli, CEB Couri, ABPL Stracieri, MC Oliveira, DA Moraes, ... Annals of the New York Academy of Sciences 1150 (1), 220-229, 2008 | 62 | 2008 |
| Does ex vi vo CD34+ positive selection influence outcome after autologous hematopoietic stem cell transplantation in systemic sclerosis patients? MC Oliveira, M Labopin, J Henes, J Moore, ND Papa, A Cras, I Sakellari, ... Bone marrow transplantation 51 (4), 501-505, 2016 | 60 | 2016 |
| Multipotent mesenchymal stromal cells from patients with newly diagnosed type 1 diabetes mellitus exhibit preserved in vitro and in vivo immunomodulatory properties JNU Yaochite, KWA de Lima, C Caliari-Oliveira, PVB Palma, CEB Couri, ... Stem cell research & therapy 7, 1-16, 2016 | 50 | 2016 |
| Onset and outcome of pregnancy after autologous haematopoietic SCT (AHSCT) for autoimmune diseases: a retrospective study of the EBMT autoimmune diseases working party (ADWP) E Snarski, JA Snowden, MC Oliveira, B Simoes, M Badoglio, K Carlson, ... Bone Marrow Transplantation 50 (2), 216-220, 2015 | 47 | 2015 |
| Autologous haematopoietic stem cell transplantation reduces abnormalities in the expression of immune genes in multiple sclerosis APA Sousa, KCR Malmegrim, RA Panepucci, DS Brum, AA Barreira, ... Clinical science 128 (2), 111-120, 2015 | 46 | 2015 |
